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S100A7 (Psoriasin): a Story of Mice 
and Men
Richard L. Eckert1,2,3,4 and Kathleen C. Lee1
S100 proteins are calcium-regulated proteins that regulate fundamental bio-
logical processes. S100A7 (psoriasin), functions as a transglutaminase substrate/
cornified envelope precursor, signal transduction protein, chemokine, and anti-
bacterial protein in normal epidermis. S100A7 is markedly increased in epider-
mal hyperproliferative disorders. The murine homolog of S100A7 and S10015 
has been identified, providing a valuable tool for studying the regulation and 
function of this protein in epidermis.
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The S100 proteins are a family of 
more than 20 low-molecular weight 
EF hand-containing calcium-regulated 
proteins that exist in cells as antiparal-
lel homo- and heterodimers. Many of 
the genes encoding this family of pro-
teins are clustered on chromosomal 
location 1q21 in the epidermal dif-
ferentiation complex (Ridinger et al., 
1998). S100 proteins have no known 
intrinsic enzymatic activity; however, 
the S100 protein dimer undergoes a 
conformational change upon calcium 
binding. This conformation change 
exposes protein domains designed to 
permit S100A7 to interact with spe-
cific target proteins, inducing them 
to modulate target protein function 
and serve as intracellular shuttle pro-
teins (Donato, 2001; Heizmann et 
al., 2002). Ultimately, activated S100 
proteins regulate fundamental cell 
processes, including cell proliferation, 
differentiation, and apoptosis (Donato, 
2001; Heizmann et al., 2002). Thirteen 
members of this protein family are 
expressed in various compartments 
in the epidermis (Eckert et al., 2004). 
S100A7 (psoriasin), S100A8 (MRP8), 
and S100A9 (MRP14) are of particu-
lar interest, as they are highly over-
expressed in wound healing, inflam-
matory and hyperproliferative skin 
diseases, and skin cancer (Broome 
et al., 2003; Madsen et al., 1992; 
Madsen et al., 1991). S100A7 levels 
are increased in psoriasis, Darier’s dis-
ease, atopic dermatitis, mycosis fun-
goides, inflammatory lichen sclerosus 
et atrophicus, and skin cancer. These 
findings suggest an important role for 
S100A7 in a variety of common skin 
diseases (Eckert et al., 2004).
S100A7 has several documented 
roles in epidermis, including function-
ing as a transglutaminase substrate/
cornified envelope precursor, signal 
transduction protein, chemokine, and 
antibacterial agent. The relative impor-
tance of these various functions in the 
context of different environmental 
stimuli or after treatment with prophy-
lactic agents is an important area of 
study. Immunohistological studies of 
cultured cells and human epidermis 
reveal that the S100A7 homodimer is 
distributed in the cytoplasm in non-
differentiated keratinocytes but redis-
tributes to the cell periphery when 
cultured keratinocytes are challenged 
with a differentiation stimulus. A simi-
lar redistribution to the cell periphery 
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is observed during epidermal differ-
entiation in vivo. This pattern of local-
ization is recapitulated in psoriatic 
tissue, except that the overall S100A7 
levels are markedly increased. These 
properties appear to be biologically 
important, as S100A7 and other S100 
proteins are transglutaminase substrates 
and are incorporated as components of 
the keratinocyte cornified envelope. 
Thus, movement to the cell periphery 
would position S100A7 in a location to 
serve as a substrate of the membrane-
anchored cornified envelope assembly 
enzyme type I transglutaminase.
In the intracellular compartment, 
S100A7 appears to interact with epi-
dermal fatty acid-binding protein (E-
FABP) (Hagens et al., 1999a; Ruse et 
al., 2003). Although E-FABP is involved 
in lipid metabolism and transport, the 
role of the intracellular S100A7–E-
FABP interaction in not known. It is 
interesting that S100A7 is also found 
in the extracellular environment. It 
is reported to be found in psoriatic 
plaque exudate, as is its binding part-
ner E-FABP. In this context, S100A7 is 
thought to have an antibacterial action 
(Glaser et al., 2005; Hagens et al., 
1999b). In addition, S100A7 may be 
released from cultured keratinocytes, 
and it may act as a chemotactic agent 
(Jinquan et al., 1996), a function that 
has been reported for S100A7 in non-
epidermal tissues.
It is important to note that the func-
tion of S100A7 may differ in normal 
versus stressed keratinocytes. The 
putative and identified functions of 
S100A7 in keratinocytes are shown 
schematically in Figure 1. In nor-
mal cultured keratinocytes, S100A7 
expression is increased by agents that 
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The S100A15 sequence 
will provide an 
important new tool 
to identify the role of 
S100A7 and S100A15 
in normal epidermal 
development and in 
cutaneous diseases and 
cancer.
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enhance keratinocyte differentiation 
(phorbol ester, calcium, etc.), a find-
ing that is consistent with the presence 
of S100A7 in the suprabasal differenti-
ated layers of epidermis (Figure 1a). 
S100A7 is presumed to exist in the 
cells as a homodimer. In response to 
the differentiation stimulus-dependent 
increase in intracellular calcium level, 
S100A7 undergoes a conformational 
change that exposes protein motifs that 
interact with E-FABP (Figure 1b). This 
interaction is associated with move-
ment of the S100A7–E-FABP complex 
to the cell periphery, where S100A7 
and E-FABP are incorporated as corni-
fied envelope components. S100 pro-
teins constitute a small fraction of the 
envelope, suggesting that they do not 
play a major structural role. Instead, 
they may serve as membrane-teth-
ered antibacterial agents. In addition, 
E-FABP has been implicated as having 
a role in lipid metabolism and intra-
cellular movement, and so S100A7 
may play a role in shuttling E-FABP 
to the proper subcellular location or 
facilitating E-FABP activity. In stressed 
keratinocytes, the role of these pro-
teins may change. Active export or cell 
breakdown may facilitate the release 
of S100A7 and E-FABP, allowing them 
to act as chemokines and/or antibac-
terial agents. In this context, S100A7 
expression level may be controlled by 
agents such as interferon.
Because this model is speculative, 
key questions regarding the role of 
S100A7 in normal differentiation and 
disease need to be addressed. First, 
is S100A7 a key stimulus that leads 
to genesis of the psoriatic phenotype, 
or is S100A7 a protein whose level is 
increased in response to conditions 
in the psoriatic environment? Second, 
what is the major role of S100A7 in 
normal keratinocyte differentiation, 
and does this role change in disease 
states? Addressing these questions will 
require extensive human studies as 
well as studies of the role of S100A7 
in murine models. Previous studies 
have identified several human S100A7 
genes and a gene encoding human 
S100A15 (Wolf et al., 2003) — which 
is 95% identical to S100A7 — that are 
clustered on chromosome 1q21 (Eckert 
et al., 2004); however, the murine 
form of the gene had not been previ-
ously reported.
In this issue, Wolf et al. (2006) 
describe the isolation of a murine S100 
gene that is assigned as the murine 
homolog to human S100A7 on the 
basis of the structure of the gene and 
its position in the genome. The phy-
logenic tree suggests that murine 
S100A15 may be the ancestral gene 
for the human S100A7 and S100A15 
genes. The isolation of this gene is the 
first identification of a murine mem-
ber of the S100A7/S100A15 family of 
proteins. Wolf et al. (2006) show that 
murine S100A15 is expressed in the 
suprabasal murine epidermal layers. In 
addition, murine S100A15 is detected 
as monomers and as high-molecular 
weight, apparently covalently cross-
linked forms, in extracts of cultured 
human keratinocytes. The accumula-
tion of high-molecular weight forms 
is increased when the cells are treated 
with agents (for example, calcium) 
that promote keratinocyte differen-
tiation and activate type I transgluta-
minase. It is striking that formation of 
high-molecular weight forms requires 
transglutaminase activity and is inhib-
ited by competitive transglutaminase 
inhibitors. In addition, these high-
molecular weight bands colocalize 
on gels with anti-isopeptide bond 
immunoreactivity, suggesting that the 
S100A15 is covalently cross-linked to 
other proteins via isopeptide bonds, 
the same linkages that are used in cor-
nified envelope assembly. Expression 
of murine S100A15 is also differen-
tiation dependent, as levels increase 
when cultured murine keratinocytes 
are treated with calcium or phorbol 
ester. The signaling pathway required 
a
b
Figure 1. Regulation of expression and mechanism of S100A7 action in keratinocytes. (a) In normal 
keratinocytes, expression of S100A7 is increased by a mechanism that is dependent on protein kinase 
C (PKC) and activator protein-1 (AP1) transcription factors. (b) S100A7 exists as a dimer in cells and, in 
response to increased intracellular calcium, forms a complex with two molecules of epidermal fatty acid-
binding protein (E-FABP). This complex (or components of the complex) is speculated to follow at least 
four possible mechanistic paths: movement to the plasma membrane, where it serves as a transglutaminase 
substrate and antibacterial entity; participation in regulation of lipid metabolism; functioning as a cytokine; 
and functioning as a released antibacterial complex. TG1, type I transglutaminase.
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HLA-Independent Antibacterial Host 
Response toward Th1 Immunity 
Mediated by IL-12: a New Concept for 
the Pathogenesis of Adamantiades–
Behçet’s Disease
Christos C. Zouboulis1,2
Yanagihori et al. found an HLA-independent higher frequency of IL-12B promot-
er polymorphism in Adamantiades–Behçet’s disease (ABD) patients than in con-
trols. Stimulation with streptococcal antigens specifically increased expression 
of patients’ peripheral blood mononuclear cells IL-12 p40/p70. The authors pro-
vide evidence for an antibacterial host response toward T-helper type 1 immunity 
mediated by IL-12 in patients with ABD, which is HLA independent.
Journal of Investigative Dermatology (2006) 126, 1444–1447. doi:10.1038/sj.jid.5700281
Adamantiades–Behçet’s disease (ABD) is 
a multisystemic, inflammatory disorder 
of unknown etiology with hyperergic 
behavior and a chronic recurrent course 
(Sakane et al., 1999). It is characterized 
by oral and genital ulcerations, various 
cutaneous manifestations, and ocular 
involvement, whereas mucocutaneous 
lesions exhibit histological changes of 
vascular reaction or vasculitis. Linked 
intrinsic and extrinsic factors are con-
sidered to contribute to the develop-
ment of the disease, and this has led to 
the concept of environmental triggering 
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for increased production of murine 
S100A15 mRNA and protein appears 
to require protein kinase C activity, 
as the calcium-dependent increase in 
murine S100A15 level is inhibited by 
protein kinase C inhibitors. Activator 
protein-1 transcription factors appear 
to be a downstream target that medi-
ates the protein kinase C-dependent 
increase in murine S100A15, as the 
presence of a dominant-negative vari-
ant of c-Jun inhibits the increase in 
murine S100A15.
It is gratifying to have confirmation 
that S100A7 expression, regulation, 
and subcellular localization are simi-
lar in human and murine epidermis. 
Moreover, it is clear that the availabil-
ity of the S100A15 sequence will pro-
vide an important new tool to identify 
the role of S100A7 and S100A15 in 
normal epidermal development and in 
cutaneous diseases and cancer.
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